By David Bautz, PhD NASDAQ: MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Phase 1 Part 3 Trial of DA-1726 to ...

Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including simplified dosing ...

Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...

Security researchers have identified a suite of powerful hacking tools capable of compromising iPhones running older software that they say has passed from a government customer into the hands of ...

Within hours of declaring that the federal government will end its use of artificial-intelligence tools made by tech company Anthropic, President Trump launched a major air attack in Iran with the ...

The United States and Israel said they carried out coordinated attacks on Iranian military and strategic targets early Saturday, with officials describing the action as a pre‑emptive operation.

In his denunciation of Anthropic, Secretary of Defense (or Secretary of War if you prefer) Pete Hegseth posted on X that “The Terms of Service of Anthropic’s ...

The medical community’s comfort with deploying AI in clinical care is rapidly evolving — because it has to, according to health informatics leaders at NYU Langone Health. They said that AI agents will ...